Benjamin Weixler1,2, Andreas Rickenbacher2,3, Dimitri Aristotle Raptis2,3, Carsten T Viehl4, Ulrich Guller5,6, Jessica Rueff2, Andreas Zettl7, Markus Zuber8. 1. Department of Surgery, University Hospital Basel, Basel, Switzerland. 2. Department of Surgery, Kantonsspital Olten, 4600, Olten, Switzerland. 3. Department of Visceral Surgery, University Hospital Zürich, Zurich, Switzerland. 4. Department of Surgery, Hospital Center Biel, Biel/Bienne, Switzerland. 5. Division of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. 6. University Clinic for Visceral Surgery and Medicine, Inselspital Berne, University of Berne, Berne, Switzerland. 7. Viollier AG, Histopathology/Cytology, Basel, Switzerland. 8. Department of Surgery, Kantonsspital Olten, 4600, Olten, Switzerland. markus.zuber@spital.so.ch.
Abstract
BACKGROUND: Sentinel lymph node (SLN) mapping was reported to improve lymph node staging in colon cancer. This study compares isosulfan blue (IB) with indocyanine green (ICG)-based SLN-mapping and assesses the prognostic value of isolated tumor cells (ITC) and micro-metastases in upstaged patients. METHODS: A total of 220 stage I-III colon cancer patients were included in this prospective single-center study. In 170 patients, SLN-mapping was performed in vivo with IB and in 50 patients ex vivo with ICG. Three levels of each SLN were stained with H&E. If negative for tumor infiltration, immunostaining for cytokeratin (AE1/3; cytokeratin-19) was performed. RESULTS: SLN detection rate for IB and ICG was 100 and 98%, respectively. Accuracy and sensitivity was 88 and 75% for IB, 82 and 64% for ICG, respectively (p = 0.244). Overall, 149 (68%) patients were node negative. In these patients, ITC and micro-metastases were detected in 26% (31/129) with IB and 17% (5/29) with ICG (p = 0.469). Patients with ITC and micro-metastases did show decreased overall survival (hazard ratio = 1.96, p = 0.09) compared to node negative disease. CONCLUSIONS: This study demonstrates a high diagnostic accuracy for both the IB and the ICG SLN-mapping. SLN-mapping upstaged a quarter of patients with node negative colon cancer, and the detected ITC and micro-metastases were an independent negative prognostic marker in multivariate analysis.
BACKGROUND: Sentinel lymph node (SLN) mapping was reported to improve lymph node staging in colon cancer. This study compares isosulfan blue (IB) with indocyanine green (ICG)-based SLN-mapping and assesses the prognostic value of isolated tumor cells (ITC) and micro-metastases in upstaged patients. METHODS: A total of 220 stage I-III colon cancerpatients were included in this prospective single-center study. In 170 patients, SLN-mapping was performed in vivo with IB and in 50 patients ex vivo with ICG. Three levels of each SLN were stained with H&E. If negative for tumor infiltration, immunostaining for cytokeratin (AE1/3; cytokeratin-19) was performed. RESULTS: SLN detection rate for IB and ICG was 100 and 98%, respectively. Accuracy and sensitivity was 88 and 75% for IB, 82 and 64% for ICG, respectively (p = 0.244). Overall, 149 (68%) patients were node negative. In these patients, ITC and micro-metastases were detected in 26% (31/129) with IB and 17% (5/29) with ICG (p = 0.469). Patients with ITC and micro-metastases did show decreased overall survival (hazard ratio = 1.96, p = 0.09) compared to node negative disease. CONCLUSIONS: This study demonstrates a high diagnostic accuracy for both the IB and the ICG SLN-mapping. SLN-mapping upstaged a quarter of patients with node negative colon cancer, and the detected ITC and micro-metastases were an independent negative prognostic marker in multivariate analysis.
Authors: Lane C Patten; David H Berger; Miguel Rodriguez-Bigas; Paul Mansfield; Ebrahim Delpassand; Karen R Cleary; Shawn P Fagan; Steven A Curley; Kelly K Hunt; Barry W Feig Journal: Cancer Date: 2004-05-15 Impact factor: 6.860
Authors: Stanley P L Leong; Markus Zuber; Robert L Ferris; Yuko Kitagawa; Ramon Cabanas; Charles Levenback; Mark Faries; Sukamal Saha Journal: J Surg Oncol Date: 2011-05-01 Impact factor: 3.454
Authors: J Weitz; M Koch; P Kienle; A Schrödel; F Willeke; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz Journal: Ann Surg Date: 2000-07 Impact factor: 12.969
Authors: Boudewijn E Schaafsma; Floris P R Verbeek; Joost R van der Vorst; Merlijn Hutteman; Peter J K Kuppen; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer Journal: J Surg Res Date: 2013-01-25 Impact factor: 2.192
Authors: Carsten T Viehl; Ulrich Guller; Christian T Hamel; Hans-Martin Riehle; Christian Plaass; Walter R Marti; Daniel Oertli; Markus Zuber Journal: World J Surg Date: 2006-03 Impact factor: 3.352
Authors: Andreas E Bembenek; Robert Rosenberg; Elke Wagler; Stephan Gretschel; Andreas Sendler; Joerg-Ruediger Siewert; Jörg Nährig; Helmut Witzigmann; Johann Hauss; Christian Knorr; Arno Dimmler; Jörn Gröne; Heinz-Johannes Buhr; Jörg Haier; Hermann Herbst; Juergen Tepel; Bence Siphos; Axel Kleespies; Alfred Koenigsrainer; Nikolas H Stoecklein; Olaf Horstmann; Robert Grützmann; Andreas Imdahl; Daniel Svoboda; Christian Wittekind; Wolfgang Schneider; Klaus-Dieter Wernecke; Peter M Schlag Journal: Ann Surg Date: 2007-06 Impact factor: 12.969
Authors: Oddmund Nordgård; Satu Oltedal; Hartwig Kørner; Ole Gunnar Aasprong; Kjersti Tjensvoll; Bjørnar Gilje; Reino Heikkilä Journal: Ann Surg Date: 2009-04 Impact factor: 12.969
Authors: E Villegas-Tovar; J Jimenez-Lillo; V Jimenez-Valerio; A Diaz-Giron-Gidi; R Faes-Petersen; A Otero-Piñeiro; F B De Lacy; R J Martinez-Portilla; A M Lacy Journal: Surg Endosc Date: 2019-11-21 Impact factor: 4.584
Authors: Michaela Ramser; Leonard A Lobbes; Rene Warschkow; Carsten T Viehl; Johannes C Lauscher; Raoul A Droeser; Christoph Kettelhack; Markus Zuber; Benjamin Weixler Journal: Int J Colorectal Dis Date: 2021-01-16 Impact factor: 2.571
Authors: Benjamin Weixler; Sofia Teixeira da Cunha; René Warschkow; Nicolas Demartines; Ulrich Güller; Andreas Zettl; Alexander Vahrmeijer; Cornelis J H van de Velde; Carsten T Viehl; Markus Zuber Journal: World J Surg Date: 2021-01-29 Impact factor: 3.352
Authors: Francesco Crafa; Serafino Vanella; Onofrio A Catalano; Kelsey L Pomykala; Mario Baiamonte Journal: World J Gastroenterol Date: 2022-08-14 Impact factor: 5.374
Authors: M Ankersmit; H J Bonjer; G Hannink; L J Schoonmade; M H G M van der Pas; W J H J Meijerink Journal: Tech Coloproctol Date: 2019-11-18 Impact factor: 3.781
Authors: Vladimir Sadkin; Viktor Sкuridin; Evgeny Nesterov; Elena Stasyuk; Alexander Rogov; Natalya Varlamova; Roman Zelchan Journal: Sci Rep Date: 2020-08-19 Impact factor: 4.379
Authors: Michaela Ramser; Rene Warschkow; Carsten T Viehl; Christoph Kettelhack; Andreas Zettl; Leonard A Lobbes; Markus Zuber; Benjamin Weixler Journal: World J Surg Date: 2021-12-27 Impact factor: 3.352